Angiologia 

Pagina 1 di 3
1 2 3  >

  • Prevention of Venous Thrombosis After Knee Replacement

    Some X-factor inhibitors, which have the advantage to be given orally in a fixed dose and don’t require any coagulation monitoring (differently from warfarin) are under study. Some examples of these drugs are rivaroxaban and apixaban.

    MedNews (Angiologia) - Mar, 9 Marzo 2010
    http://mn.medsurfnews.com/

  • Post-Thrombotic Syndrome After DVT

    There are not clear data yet on the incidence and the risk factors of a post-thrombotic syndrome after an episode of deep venous thrombosis (DVT). Through a prospective cohort trial, 387 patients with DVT in eight hospitals in Canada have been treated with heparin followed by warfarin and monitored after 1, 4, 8, 12 and 24 months.

    MedNews (Angiologia) - Ven, 15 Maggio 2009
    http://mn.medsurfnews.com/

  • Statins May Be Useful for Systemic Sclerosis Manifestations

    The results of a randomized trial suggest that statins may be a useful treatment for Raynaud's phenomenon and digital ulcers that can accompany systemic sclerosis.

    Medscape (Angiologia) - Mer, 24 Settembre 2008
    http://www.medscape.com

  • Foam Sclerotherapy for Varicose Veins Linked to Microembolism

    Researchers are reporting that microembolism of foam particles is common during foam sclerotherapy for varicose veins, and among patients with patent foramen ovale (PFO), these microemboli might be linked to neurologic symptoms.

    Medscape (Angiologia) - Ven, 4 Aprile 2008
    http://www.medscape.com

  • Gene Variants Associated With Deep Vein Thrombosis

    Objective of the study is to identify single-nucleotide polymorphisms (SNPs) associated with DVT.

    Journal of the American Medical Association (Angiologia) - Mer, 19 Marzo 2008
    http://jama.ama-assn.org/

  • Genes that protect against atherosclerosis identified

    One way of combating atherosclerosis is to reduce levels of "bad cholesterol" in the blood. Scientists at the Swedish medical university Karolinska Institutet have now identified the genes that bring about this beneficial effect.

    Karolinska Institutet (Angiologia) - Mer, 19 Marzo 2008
    http://ki.se/ki/jsp/polopoly.jsp?d=130&l=en

  • Idraparinux versus Standard Therapy for Venous Thromboembolic Disease

    The long-acting factor X inhibitor idraparinux was compared with a standard antithrombotic regimen in two randomized trials, one for the treatment of deep venous thrombosis (DVT Study) and the other for the treatment of pulmonary embolism (PE Study).

    New England Journal of Medicine (Angiologia) - Gio, 13 Settembre 2007
    http://www.nejm.org

  • Duration Of Venous Thromboembolism Therapy

    Even if the codified period of treatment for venous thromboembolism is of three months, it is still discussed whether is it opportune to continue therapy beyond this term.

    MedNews (Angiologia) - Mar, 11 Settembre 2007
    http://mn.medsurfnews.com/

  • Treatment of Kawasaki Disease

    The standard treatment of Kawasaki disease uses intravenous immunoglobulins associated with ASA, while favourable results obtained with cortisone in complicated forms of the disease have driven some clinicians to add these substances to the basic therapy of the disease.

    MedNews (Angiologia) - Dom, 29 Luglio 2007
    http://mn.medsurfnews.com/

  • Study results released on travel and blood clots

    WHO today released results from Phase I of the WHO Research Into Global Hazards of Travel (WRIGHT) project. Findings indicate that the risk of developing venous thromboembolism (VTE) approximately doubles after travel lasting four hours or more.

    World Health Organization (Angiologia) - Gio, 5 Luglio 2007
    http://www.who.int
1 2 3  >
Pagina 1 di 3